Ecke, T.H.; Voß, P.C.; Schlomm, T.; Rabien, A.; Friedersdorff, F.; Barski, D.; Otto, T.; Waldner, M.; Veltrup, E.; Linden, F.;
et al. Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment. Int. J. Mol. Sci. 2022, 23, 7898.
https://doi.org/10.3390/ijms23147898
AMA Style
Ecke TH, Voß PC, Schlomm T, Rabien A, Friedersdorff F, Barski D, Otto T, Waldner M, Veltrup E, Linden F,
et al. Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment. International Journal of Molecular Sciences. 2022; 23(14):7898.
https://doi.org/10.3390/ijms23147898
Chicago/Turabian Style
Ecke, Thorsten H., Paula Carolin Voß, Thorsten Schlomm, Anja Rabien, Frank Friedersdorff, Dimitri Barski, Thomas Otto, Michael Waldner, Elke Veltrup, Friederike Linden,
and et al. 2022. "Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment" International Journal of Molecular Sciences 23, no. 14: 7898.
https://doi.org/10.3390/ijms23147898
APA Style
Ecke, T. H., Voß, P. C., Schlomm, T., Rabien, A., Friedersdorff, F., Barski, D., Otto, T., Waldner, M., Veltrup, E., Linden, F., Hake, R., Eidt, S., Roggisch, J., Heidenreich, A., Rieger, C., Kastner, L., Hallmann, S., Koch, S., & Wirtz, R. M.
(2022). Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment. International Journal of Molecular Sciences, 23(14), 7898.
https://doi.org/10.3390/ijms23147898
